Skip to content
MedGenome – Leading Genetics Diagnostics Lab in India
MedGenome – Leading Genetics Diagnostics Lab in India
Menu
About Us
Tests & Services
Claria
Non-invasive prenatal screening test (NIPT)
Carrier Screening
PGT-A/PGT-M, S
Recurrent Pregnancy Loss Test
Molecular Cytogenetics
Rhesus D Track
More...
Actia
Molecular Test
FSHD1
Rapid Exome
ExomeMax
Clinical Exome
Chromosomal Microarray
Whole Exome
Trio Exome
Polygenic Risk Score for CAD
Panels
Neuro Genetics
Nephro Genetics
Cardio Genetics
Endocrine Genetics
Metabolic Genetics
Ocular Genetics
ENT Genetics
More...
Prima
Molecular Test
Molecular testing for Solid Tumors
Molecular testing for Hematological Malignancies
Panels
LungTrack Advance
Tumor Mutation Burden
TumorTrack Advance
BRCA1 and BRCA2 Gene Test
HLA Typing
Liquid Biopsy
clonoSEQ® NGS MRD
Thalassemia Mutation Testing
Immunophenotyping by Flowcytometry
Thyrotrack
More...
Micra
COVID-19 (SARS-CoV2) RT-PCR Test
SPIT SEQ
TB Diagnostics Solution
Gastrointestinal Infections
Syndrome Evaluation System (SES)
SES for CNS Infections
SES for Systemic Infections
SES for Eye Infections
More...
Immucare
RESEARCH SERVICES
Resources
Blog
Brochures
Publications
Patient Stories
Videos
Insights
Coronary Artery Disease
BRCA1 and BRCA2
NIPT
Genetic Counseling
Rare Diseases
HLA Typing
Genetic Insights
DNA Insights
Request Test Details
Schedule Genetic Counselling
Choose the region
Region:
Press
2023
2022
2021
2020
2019
2018
2017
December
November
October
September
August
July
June
May
April
March
February
January
January
Gallbladder cancer vaccine candidates identified – PR Newswire
×
Gallbladder cancer vaccine candidates identified – Biovoice
×
MedGenome identifies vaccine candidates for gall bladder cancer – BioSpectrum
×
Scientists identify vaccine candidate for gallbladder cancer amid COVID-19 pandemic-Times Now
×
Experts develop a breakthrough genetic risk score for Heart Disease in South Asia – ETHealthworld
×
MedGenome looks to market novel screening test for coronary artery disease – Business Standard
×
CAD: Bengaluru firm studies genetic risk in South Asian population – The Times of India
×
Business disruption and opportunities that emerge – Forbes
×
Toll free number: 1800 103 3691
diagnostics@medgenome.com
Enquire Now
Call Now